Clinical Trials Browser

Phase 3 × Colorectal Neoplasms, Hereditary Nonpolyposis × spartalizumab × Clear all

NCT04711434 2021-01-20

PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients

Phase 3 Unknown

Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis